Hi everyone, just found this company and rather taken aback by its current SP. I'd be interested if anyone can give me a logical reason as to why this isn't trading at $0.16 instead of around $16.00, based on the poor financials, lack of a demo product, auditor's qualifying remarks, con notes, relatively substantial corporate and management expenses, and chequered history.
Great potential and all that, but nothing here that remotely justifies its current SP from my point of view, until there's a proven product out there at the very least.
Thanks for responses.
- Forums
- ASX - By Stock
- AKP
- Ann: Integration Stage Update
Ann: Integration Stage Update, page-125
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AKP (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.20 |
Change
0.000(0.00%) |
Mkt cap ! $181.1M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AKP (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online